Author:
Dai Guidong,Li Benpeng,Xu Yuping,Zeng Zhuliang,Yang Hongyun
Funder
National Natural Science Foundation of China
Reference39 articles.
1. Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course;Baldi;Ther. Clin. Risk Manag.,2014
2. Pulmonary hypertension: diagnostic and therapeutic challenges;Bazan;Ther. Clin. Risk Manag.,2015
3. Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials;Böger;Vasc. Med.,2005
4. Attenuation of bleomycin-induced lung fibrosis by oxymatrine is associated with regulation of fibroblast proliferation and collagen production in primary culture;Chen;Basic. Clin. Pharmacol. Toxicol.,2008
5. Nitric oxide and pulmonary arterial hypertension;Chester;Glob. Cardiol. Sci. Pract.,2017
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献